NasdaqCM - Nasdaq Real Time Price USD
Hoth Therapeutics, Inc. (HOTH)
1.3000
+0.0900
+(7.44%)
At close: June 6 at 4:00:01 PM EDT
1.2809
-0.02
(-1.47%)
After hours: June 6 at 7:59:23 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | -- |
Avg. Estimate | -0.27 | -0.23 | -0.97 | 0 |
Low Estimate | -0.27 | -0.23 | -0.97 | 0 |
High Estimate | -0.27 | -0.23 | -0.97 | 0 |
Year Ago EPS | -0.24 | -0.31 | -1.28 | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | -0.43 | -0.3 | -0.43 | -0.34 |
EPS Actual | -0.24 | -0.31 | -0.32 | -0.27 |
Difference | 0.19 | -0.01 | 0.11 | 0.07 |
Surprise % | 44.19% | -3.33% | 25.58% | 20.59% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.27 | -0.23 | -0.97 | 0 |
7 Days Ago | -0.25 | -0.22 | -0.87 | 0 |
30 Days Ago | -0.25 | -0.22 | -0.87 | 0 |
60 Days Ago | -0.25 | -0.22 | -0.87 | 0 |
90 Days Ago | -0.19 | -0.19 | -0.78 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | 1 | 1 | 1 | -- |
Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
HOTH | -12.50% | 25.81% | 24.22% | -- |
S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
Maintains | D. Boral Capital: Buy to Buy | 4/15/2025 |
Maintains | D. Boral Capital: Buy to Buy | 4/3/2025 |
Maintains | D. Boral Capital: Buy to Buy | 3/31/2025 |
Maintains | D. Boral Capital: Buy to Buy | 3/10/2025 |
Maintains | D. Boral Capital: Buy to Buy | 3/6/2025 |
Maintains | D. Boral Capital: Buy to Buy | 3/4/2025 |
Related Tickers
CLRB Cellectar Biosciences, Inc.
0.3608
-11.59%
LIMN Liminatus Pharma, Inc.
24.22
-1.54%
EYEN Eyenovia, Inc.
4.8800
+55.41%
BMEA Biomea Fusion, Inc.
2.4900
+1.63%
PSTV Plus Therapeutics, Inc.
0.3255
+2.04%
TRAW Traws Pharma, Inc.
1.6500
+11.49%
SILO Silo Pharma, Inc.
0.5811
-9.20%
SGMT Sagimet Biosciences Inc.
5.56
+16.32%
IMNN Imunon, Inc.
1.4600
+4.29%
LYEL Lyell Immunopharma, Inc.
12.76
+11.34%